Kevin Joseph Fitzgerald Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

Kevin Joseph Fitzgerald is CSO & EVP, Head of Research of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 14,181 shares of ALNY, which is worth approximately $3.62 Million. The most recent transaction as insider was on Jun 25, 2024, when has been sold 1,198 shares (Common Stock) at a price of $229.42 per share, resulting in proceeds of $274,845. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.2K

n/a 3M change

n/a 12M change

Total Value Held $3.62 Million

Kevin Joseph Fitzgerald Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 25 2024	SELL Open market or private sale	$274,845 $229.42 p/Share	1,198 Reduced 7.79%	14,181 Common Stock
Jun 24 2024	BUY Grant, award, or other acquisition	-	2,498 Added 13.97%	15,379 Common Stock

Also insider at

OVID

Ovid Therapeutics Inc. Healthcare

Director

KJF